Literature DB >> 17300711

The prevalence of atherosclerosis in cirrhotic patients: assessment of two aspects of atherosis and sclerosis.

Manri Kawakami1, Masahiko Koda, Yoshikazu Murawaki.   

Abstract

AIM: In general, cirrhotic patients are known to have a low prevalence of cardiovascular disease. Cirrhosis is often accompanied by diabetes mellitus, while blood pressure and serum cholesterol levels are low in liver cirrhosis. We examined the atherosclerosis of patients with chronic liver disease by two phases of atherosis "lipid deposition" and sclerosis "arterial fibrosis."
METHODS: Atherosis was assessed by carotid intima-media thickness and the ratio of the systolic blood pressure at the ankle to the average systolic blood pressure at the right arm (ankle brachial pressure index), while sclerosis was evaluated by brachial ankle pulse wave velocity.
RESULTS: There were no significant differences in intima-media thickness and ankle brachial index among grades of cirrhosis. Brachial ankle pulse wave velocity decreased closely as the severity of cirrhosis progressed (F = 4.90, P < 0.05). In univariate analysis, brachial ankle pulse wave velocity was correlated with systolic blood pressure, age, total bilirubin, albumin, prothrombin time, retention rate of indocyanine green at 15 min, blood ammonia, branched chain amino acids/tyrosine molar rate and fasting blood sugar. Multiple regression analysis showed that systolic blood pressure and total bilirubin were independent factors for the inhibition of vascular sclerosis progression.
CONCLUSION: Although no difference in atherosis between cirrhotic patients and healthy controls was found, vascular sclerosis was decreased with the severity of cirrhosis through hypotension and hyperbilirubinemia.

Entities:  

Year:  2007        PMID: 17300711     DOI: 10.1111/j.1872-034X.2007.00023.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  4 in total

1.  Hepatic artery aneurysm in a patient with hepatitis C liver cirrhosis: report of a case.

Authors:  Yu Saito; Tomoharu Yoshizumi; Noboru Harada; Hiroto Kayashima; Koji Yamasaki; Noriaki Sadanaga; Hiroshi Matsuura; Kenichiro Okadome
Journal:  Clin J Gastroenterol       Date:  2013-03-09

2.  Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Authors:  Karen V Danielsen; Signe Wiese; Jens Hove; Flemming Bendtsen; Søren Møller
Journal:  Dig Dis Sci       Date:  2018-03-08       Impact factor: 3.199

3.  Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients With Rheumatoid Arthritis Compared With Patients With Osteoarthritis.

Authors:  Gabriel-Santiago Rodríguez-Vargas; Pedro Santos-Moreno; Jaime-Andrés Rubio-Rubio; Paula-Katherine Bautista-Niño; Darío Echeverri; Luz-Dary Gutiérrez-Castañeda; Fabio Sierra-Matamoros; Stephania Navarrete; Anggie Aparicio; Luis Saenz; Adriana Rojas-Villarraga
Journal:  Front Cardiovasc Med       Date:  2022-07-05

4.  Novel markers of endothelial dysfunction in hepatitis C virus-related cirrhosis: More than a mere prediction of esophageal varices.

Authors:  Amr Shaaban Hanafy; Mohamed Abdel Khalik Basha; Fady Maher Wadea
Journal:  World J Hepatol       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.